Duquesne Family Office »

Adma Biologics shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.6M 252k 18.24

More positions owned by Duquesne Family Office

Natera (NTRA)
Select Sector Spdr Tr State Street Fin (XLF)
Insmed Com Par $.01 (INSM)
Ishares Msci Brazil Etf (EWZ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Woodward Governor Company (WWD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Coupang Cl A (CPNG)
Alphabet Cap Stk Cl A (GOOGL)
Sea Sponsord Ads (SE)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
MercadoLibre (MELI)
Bbb Foods Cl A Com (TBBB)

View all positions for Duquesne Family Office

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Caligan Partners

View all funds holding Adma Biologics